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The success of bioengineered dental pulp depends on two principles, (1) whether the transplanted tissue can
develop its own vascular endothelial tubule network and (2) whether the host vasculature can be induced to
penetrate the bioengineered pulp replacement and conjoin. Major inductive molecules that participate in laying
down blood vessels include vascular endothelial growth factor (VEGF), ephrinB2, and hypoxia-inducible factor
1a (HIF-1a). Being able to modulate the genes encoding these angiogenic molecules is a therapeutic target in
pulp regeneration for endogenous blood vessel formation, prevention of graft rejection, and exclusion of
infection. Once implanted inside the root canal, bioengineered pulp is subjected to severe hypoxia that causes
tissue degeneration. However, short-term hypoxia is known to stimulate angiogenesis. Thus, it may be feasible
to prime dental cells for angiogenic activity before implantation. Stem cells from apical papilla (SCAP) are
arguably one of the most potent and versatile dental stem cell populations for bioengineering pulp in vitro. Our
study aimed to investigate whether coculture of SCAP and human umbilical vein endothelial cells (HUVECs)
under hypoxia promotes the formation of endothelial tubules and a blood vessel network. In addition, we
clarified the interplay between the genes that orchestrate these important angiogenic molecules in SCAP under
hypoxic conditions. We found that SCAP cocultured with HUVEC at a 1:5 ratio increased the number of
endothelial tubules, tubule lengths, and branching points. Fluorescence staining showed that HUVEC formed
the trunk of tubular structures, whereas SCAP located adjacent to the endothelial cell line, resembling the
pericyte location. When we used CoCl2 (0.5mM) to induce hypoxic environment, the expression of proteins,
HIF-1a and VEGF, and transcript of ephrinB2 in SCAP was upregulated. However, minimal VEGF levels in
supernatants of HUVEC and coculture Petri dishes were detected, suggesting that VEGF secreted by SCAP
might be used by HUVEC to accelerate the formation of vessel-like structures. Taken together, we revealed that
artificial hypoxia stimulates angiogenic responses in SCAP for possible use in engineering dental pulp re-
placements. Our results may help to delineate the optimal therapeutic target to promote angiogenesis so that
future bioengineered pulp replacements integrate faster and permanently within the host.
Introduction
Teeth with infected or necrotic pulp because oftrauma, caries, and operative procedures are mainly
treated by removal of the entire pulp and subsequent re-
placement with artificial fillings.1 Loss of vitalized dental
pulp invariably makes the tooth more susceptible to repeated
infection, fracture, and eventually ejection from its socket.
Engineered living tissue replacements are alternative be-
cause they ensure restoration of whole tooth health by pre-
venting infection and maintaining structural integrity.
Numerous regenerative strategies are currently under in-
vestigation. The most common strategy implements stem
cell-laden frameworks to accelerate the production of new
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pulp merged with dentine.2–4 Five distinctive and well-
characterized stem cell populations have been discovered
with strong clinical potential to generate various new per-
manent dental tissues in vitro. These populations include
stem cells from apical papilla (SCAP), periodontal ligament
stem cells, dental pulp stem cells (DPSCs), stem cells from
human exfoliated deciduous teeth, and dental follicle stem
cells (DFSCs).5,6 SCAP and DFSCs are less studied than
DPSCs, but they are the most potent and perhaps the most
plastic type of stem cells.7 As therapeutic stem cells, SCAP
appear to be the most reliable because they are easily har-
vested from extracted premolars or wisdom teeth and have
the ability to differentiate into osteogenic, odontogenic,
adipogenic, angiogenic, and neurogenic lineages.8,9
Pulp connective tissue occupies the entire root canal into
the center of each tooth, which is surrounded by a case of
dentine. There is only one blood supply line to the entire
pulp, which originates from the tight opening of the apical
foramen.10 This blood supply provides 80% of the total
blood supply to the pulp tissue. In severe traumatic injuries
or inflammation at any region of the tooth, the neurovascular
bundle can be severely disrupted, leading to ischemia in the
pulp tissue itself.11 The small space leading into the pulp
cavity is also a major obstacle for dental pulp regeneration,
because any engineered pulp tissues needs heavy neo-
vascularization and rapid infusion into the host vascular
system immediately after transplantation.10 Without normal
oxygen levels, dental pulp cell metabolism, nourishment,
and behavior are all compromised.12
Therefore, all transplanted pulp tissue replacements must
be given a blood supply to ensure healthy and optimal
function. A strategy to assist with blood supply is to induce
angiogenesis at the host tissue interface. One method to
reinitiate angiogenesis is stimulating the expression of the
hypoxia-inducible factor (HIF) family of transcription reg-
ulators.13 Thus, although hypoxia should be avoided within
any bioengineered construct, a degree of oxygen limitation
is actually necessary to prime exogenous dental cells for
vasculogenic and angiogenic responses.
Ubiquitously expressed HIF-1 consists of two basic hetero-
dimeric proteins, a subunit (HIF-1a) and b subunit (HIF-1b).
HIF-1a expression is rapidly activated under hypoxic condi-
tions (< 5% oxygen), whereas HIF-1b is constitutively ex-
pressed in an oxygen-independent manner.14 Accumulation
and translocation of HIF-1a into the nucleus is a major driving
force for angiogenesis.12–15 EphrinB2 and its receptor, EphB4,
have emerged as critical regulators in the development of the
vascular system and contribute to the function of adult vascu-
lature with comparable importance to vascular endothelial
growth factor (VEGF) and angiopoietins.15,16 EphrinB2 is
expressed in adult arteries, arterioles and capillaries, whereas
EphB4 is expressed predominantly in endothelial cells (ECs) of
venous origin. Under physiological and pathological condi-
tions, ephrinB2 expression and phosphorylation are increased
in angiogenic vessels. This pattern of EphB4/ephrinB2 ex-
pression is closely related to EC growth, survival, migration,
and angiogenesis.16 Recent studies have revealed that various
Eph/ephrin family members are expressed during tooth de-
velopment.17 When cocultured with human umbilical vein
endothelial cell (HUVEC), DPSCs significantly enhance and
stabilize tube-like structures generated by the assembled HU-
VEC populations.18 After treatment with soluble fms-like ty-
rosine kinase-1 (sFlt-1, also referred to as sVEGFR-1) to block
VEGF binding to VEGFR-2, DPSCs exhibit decreased ex-
pression of ephrinB2 and subsequently induce less vessel for-
mation in vivo.19 However, the precise role has not been
revealed for ephrinB2 from dental stem cells in angiogenesis.
In this study, we aimed to investigate (1) whether coculture
of SCAP and HUVEC under hypoxia promotes the formation
of endothelial tubules and a blood vessel network, (2) the
expression profiles of angiogenesis-related genes encoding
HIF-1a, VEGF, and EphB4/ephrinB2 molecules in SCAP
under hypoxia, (3) the individual and synergistic roles of
SCAP angiogenic activities when cocultured with HUVEC.
Materials and Methods
Isolation, culture, and characterization of SCAP
After obtaining informed consent, SCAP were isolated
from freshly extracted human third molars with immature
roots (aged 18–25 years) as described previously.8 Briefly,
the root apical papilla was removed from the end and
digested in a solution of 3mg/mL collagenase type I (Gibco-
Invitrogen, Carlsbad, CA) and 4mg/mL dispase (Gibco-
Invitrogen) for 1 h at 37C. Then, the cells were passed
through a 70-mm strainer (BD Biosciences, Franklin Lakes,
NJ) to obtain a single cell suspension. The cells were seeded
in 75-cm2 culture flasks containing a-minimum essential
medium (a-MEM; Gibco BRL, Gaithersburg, MD) supple-
mented with 15% fetal bovine serum (Gibco BRL), 0.292mg/
mL glutamine (Sigma, St. Louis, MO), 100U/mL penicillin
(Sigma), 100mg/mL streptomycin (Sigma), and cultured at
37C with 5% CO2. HUVEC were obtained commercially
(ScienCell Research Laboratories, San Diego, CA) and cul-
tured in EC medium (ScienCell Research Laboratories) at
37C with 5% CO2. Before using SCAP for experiments, the
freshly isolated cells were assessed for their stemness by
flow cytometric analysis of the expression of CD73, CD90,
CD105, STRO-1, and CD45. In addition, the multilineage
differentiation capacity of SCAP was confirmed using oste-
ogenic and odontogenic, adipogenic, and neurogenic induc-
tion media. Passage 3–6 cells were used in experiments to
ensure retention of their stem cell qualities.
Hypoxic culture conditions
SCAP grown to 80–90% confluence were trypsinized and
counted. For hypoxic conditions, cells were seeded at a
density of 3 · 105 cells/mL in six-well plates and cultured
for 3 days to achieve 80–90% confluence. Then, the cells
were starved with serum-free medium for 12 h followed by
incubation with 0.5mM CoCl2 (Sigma). At various time
points, mRNA and proteins were harvested from the cells
for subsequent analyses. All experiments were performed in
triplicate.
For experiments with HIF-1a inhibitors, the cells were
pretreated with 80 mM YC-1 (AG Scientific, San Diego, CA)
for 2 h before hypoxic stimulation. Normoxic and hypoxic
cultures without inhibitors were used as controls.
In vitro matrigel angiogenesis assay
To investigate whether coculture of SCAP and HUVEC
under hypoxia promotes formation of endothelial tubules
and a blood vessel network, tubular formation assay was
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carried out as described previously.18 Briefly, HUVECs
(6 · 105) alone or cocultured with SCAP (SCAP:HUVEC,
1:5) were seeded in six-well plates precoated with Matrigel
(1.5mL/well; BD Biosciences). CoCl2 (0.5mM) was added
to the medium of experimental group to mimic hypoxic
environment. Images were obtained under an inverted
phase-contrast microscope after 6 h and analyzed with the
Leica Qwin Image Processing and Analysis Software
(Version V2.6; Leica, Cambridge, United Kingdom). Tubule
length, junctional areas, and the number of branching points
were measured in images at 10 ·magnification (n = 5). Cell
lysates and supernatants were collected and detected using
western blot and enzyme-linked immunosorbent assay
(ELISA). To distinguish HUVEC and SCAP in vessel-like
structures, CellTracker fluorescent probes (Invitrogen,
Carlsbad, CA) were used to label them. SCAPs were stained
with orange fluorescence and HUVECs were stained with
green fluorescence. Images were obtained under fluores-
cence microscope.
Cell sorting after coculture of HUVEC and SCAP
To detect VEGF mRNA expression in HUVEC and
SCAP after coculture, Dynabeads CD31 Endothelial Cell
(Life Technologies AS, Oslo, Norway) was used to sepa-
rate HUVEC from SCAP. Briefly, cells were harvested
using Dispase (Corning, Tewksbury, MA) after 3 h of co-
culture in Matrigel. Then, 1mL single cell suspension was
mixed with 25 mL prewashed magnetic beads, and incu-
bated for 20min at 4C under gentle rotation. The tube
was then placed in a magnet for 2min. Finally, the su-
pernatant containing the cocultured SCAP (co-SCAP) was
transferred to a new tube, and bead-bound HUVEC (co-
HUVEC) was left on the tube wall. 350 mL Buffer RLT
Plus RNeasy Plus lysis buffer (QIAGEN GmbH, Hilden,
Germany) was used to lyse cell pellet. Real-time PCR was
performed to detect VEGF gene expression in SCAP and
HUVEC, respectively. SCAP or HUVEC incubated alone
in Matrigel was used as control.
Real-time polymerase chain reaction
Total RNA was extracted using an RNeasy Mini Kit
(Qiagen, Hilden, Germany). RNA concentrations were
quantified using a NanoDrop ND-1000 spectrophotometer
(NanoDrop Technologies, Wilmington, DE). Total RNA
(2 mg) was then used to synthesize cDNA by the Super-
Script VILO Master Mix (Invitrogen). Quantitative real-
time polymerase chain reaction (PCR) was performed using
an ABI Prism 7000 Sequence Detection System (Applied
Biosystems, Carlsbad, CA) with SYBR Green (Applied
Biosystems). All samples in 96-well plates were run in
triplicate. Each well contained 2 mL cDNA diluted at 1:3 for
a total reaction volume of 20mL. PCR conditions were
initial denaturation for 10min at 95C, followed by 40 cy-
cles of denaturation for 15 s at 95C, and annealing for 1min
at 60C or 64C (primer specific). Amplicons were sub-
jected to melting point analyses by heating for 1min from
95C to 60C. All primers were purchased from Sigma and
are listed in Table 1. The mRNA levels of HIF-1a, VEGF,
EphB4, and ephrinB2 were determined and normalized to
the GAPDH internal control. Standards and samples were
run in triplicate.
Western blot analyses
To assess the effects of hypoxia on the synthesis of HIF-
1a, EphB4, and ephrinB2 proteins, SCAP grown in 10-cm
culture dishes were treated with 0.5mM CoCl2 for 0, 2, 4, 8,
and 24 h. For inhibition experiments, the cells were pre-
treated with 80 mM YC-1 for 2 h followed by hypoxic
stimulation.
After each treatment, the cells were rinsed twice with
phosphate buffered saline. Then, total protein was obtained
using M-PER protein extraction buffer containing 3 ·
protease inhibitor cocktail (Thermo Scientific, Rockford,
IL). Cellular proteins were quantified by a BCA kit
(Pierce, Rockford, IL), and then separated on 7.5% or 12%
polyacrylamide gels followed by transfer onto the Immun-
Blot polyvinylidene fluoride membranes (GE Healthcare
Life Sciences, Little Chalfont, United Kingdom). The
membranes were blocked for 1 h with 5% nonfat milk
powder in Tris-phosphate buffer containing 0.05% Tween
20 (TBST). Then, the membranes were incubated over-
night at 4C with primary antibodies, including anti-
HIF-1a polyclonal antibody (1:400; BD Transduction
Laboratories, San Jose, CA), anti-EphB4 polyclonal anti-
body (1:100; Abcam, Hong Kong, China), anti-ephrinB2
polyclonal antibody (1:200; Abcam), and anti-b-actin
monoclonal antibody (1:800; Santa Cruz Biotechnology,
Santa Cruz, CA). After five washes with TBST for 5min
each, the membranes were incubated with horseradish
peroxidase-conjugated secondary antibodies (Cell Signal-
ing Technology, Danvers, MA) for 2 h at room tempera-
ture, and then washed three times in TBST for 5min each.
The target protein signal was detected using ECL (Thermo
Scientific).
Enzyme-linked immunosorbent assay
VEGF expression was measured by Quantikine ELISA
(R&D Systems, Minneapolis, MN). Briefly, the supernatants
were collected and centrifuged to remove particulates. We
pipetted 500 mL of Calibrator Diluent RD5K into each tube,
and used stock solution to produce a dilution series, then
added 50 mL of Assay Diluent RD1W and 200mL of stan-
dard, control, or sample to each well. After washing three
times, 200 mL of VEGF Conjugate was added to each well
and incubated at room temperature for 2 h, then 200mL of
Table 1. Primer Sequences Used for Real-Time
Polymerase Chain Reaction
Gene Primers










HIF-1a, hypoxia-inducible factor 1a; VEGF, vascular endothelial
growth factor.
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the substrate solution was added to each well, protected
from light, and incubated it at room temperature for 20min.
Finally, we added 50mL of Stop Solution to each well, and
determined the optical density of each well using a micro-
plate reader at 450 and 570 nm.
Statistical analysis
Relative expression levels of genes, tubular junctional areas,
and tubule lengths were presented as the mean– standard de-
viation. Data were analyzed using the Student’s t-test or one-
way analysis of variance with a post hoc Tukey test to compare
between groups as appropriate. p<0.05 was considered sta-
tistically significant.
Results
Isolated SCAP exhibit stem cell properties
SCAP were a typical fibroblastic spindle shape when
cultured in a-MEM. Flow cytometric analyses showed that
SCAP highly expressed CD73, CD90, and CD105, and
weakly expressed CD45, whereas 26.35% of SCAP ex-
pressed STRO-1 (Fig. 1A). Neurogenic induction caused
morphological changes in the cells and expression of the
neurogenic marker bIII-tubulin (Fig. 1B). Oil Red O stain-
ing revealed that lipid droplets had formed in experimental
groups after 3 weeks of adipogenic induction (Fig. 1C).
Alizarin Red staining showed obvious mineralization of
SCAP after 4 weeks of odontogenic and osteogenic induc-
tion (Fig. 1D).
Coculture of SCAP and HUVEC under hypoxia
enhances the formation of vessel-like structures
HUVECs seeded on Matrigel alone formed a small
number of vessel-like structures after 6 h (Fig. 2A), whereas
those cocultured with SCAP (Fig. 2B) or incubated under
hypoxic conditions (Fig. 2C) formed more vessel-like
structures. When HUVECs and SCAPs were cocultured
under hypoxia, we detected the most extensive lattice of
vessel-like structures among all groups (Fig. 2D). Using
immunofluorescence microscopy, we found that HUVEC
formed the trunk of tubular structures (Fig. 2E), and SCAP
located adjacent to the EC line (Fig. 2F). Compared with the
HUVEC control group, the other three groups had longer
tubule lengths (Fig. 2G) and higher number of branching
points (Fig. 2H). The tubular junctional areas of hypoxia and
coculture groups were also smaller than those of the HU-
VEC alone groups (Fig. 2I).
VEGF expression in SCAP and HUVEC
The average concentration of VEGF protein in superna-
tants secreted by SCAP under normoxia was 205 pg/mL
(Fig. 3A). When SCAPs were incubated in hypoxia, VEGF
expression increased and its concentration reached to
1249 pg/mL (Fig. 3A). VEGF mRNA expression in SCAP
under hypoxia was upregulated time dependently. The
highest VEGF mRNA level was observed after 4 h of in-
cubation under hypoxia (5.8-fold, Fig. 4B). Compared with
SCAP, HUVEC secreted less VEGF protein (15 pg/mL).
Surprisingly, when SCAP was cocultured with HUVEC,
VEGF concentration in supernatants was also very low
(35 pg/mL). To reveal its mechanism, we used magnetic
beads to separate HUVEC from SCAP after 3 h of coculture;
real-time PCR results showed that mRNA expression be-
tween SCAP and co-SCAP had no significant difference, but
was upregulated in co-SCAP under hypoxia (Fig. 3B).
VEGF mRNA levels in HUVEC, co-HUVEC, or co-HU-
VEC under hypoxia were much lower than in SCAP, co-
SCAP, or co-SCAP under hypoxia (Fig. 3B).
HIF-1a and ephrinB2 in SCAP under hypoxia are
upregulated
Real-time PCR results showed that HIF-1a mRNA was
upregulated after 4 h of hypoxia (Fig. 4A). The HIF-1a
protein was barely detectable under normoxia, but its ex-
pression was induced obviously under hypoxic conditions
and reached a maximum after 4 h of exposure (15.7-fold
compared with the 2 h group, Fig. 5).
EphrinB2 mRNA expression was induced quickly,
peaked after 2 h (2.25-fold), and then fluctuated until 8 h of
hypoxia (Fig. 4C). Subsequently, ephrinB2 mRNA expres-
sion decreased to a normal level after 12 h. Western blot
results showed that there were no significant changes of
ephrinB2 protein levels in normoxia and hypoxia groups
(Fig. 5A). EphB4, which is a cognate receptor of ephrinB2,
also showed steady protein levels after hypoxic induction
(Fig. 5A), whereas EphB4mRNA expression decreased
constantly after hypoxic induction (Fig. 4D).
Hypoxia-dependent upregulation of VEGF
and ephrinB2 expression is mediated by HIF-1a
To directly demonstrate that the upregulation of ephrinB2
and VEGF expression under hypoxia was mediated by HIF-
1a, we used YC-1 to suppress HIF-1a expression. After a
series of preliminary experiments, we found that 80 mM YC-
1 suppressed HIF-1a expression thoroughly (Fig. 6A). After
treatment with 80mM YC-1, the hypoxia-dependent upre-
gulation of HIF-1a, VEGF, and ephrinB2 expression was
abrogated (Fig. 6B, C).
Discussion
Rapid and sufficient blood perfusion is necessary for the
integration and survival of in vitro bioengineered tissue
constructs.20 Several strategies have been developed to ac-
celerate angiogenesis and thus overcome the strict diffusion
limits imposed inside bioengineered tissues that are thicker
than 500mm. Such strategies include the provision of vari-
ous proangiogenic factors,21,22 genetic modification of cells
to overproduce growth factors,23,24 specific biomaterial de-
sign to mimic the extracellular matrix with high porosities,25
and embedding ECs into engineered tissue constructs.26,27
However, the time required for EC migration, angiogenic
sprouting, and vasculogenesis is still too long to guarantee
the viability of bioengineered tissue after implantation and
for it to merge and fuse with host tissue.28 It has been re-
ported that extensive networks are formed at day 5 when
engineered replacements are prevascularized with HUVEC
before implantation.29 The space of the root canal is en-
capsulated by dentin in the center of each tooth with only a
single blood supply from its apical end.30 This anatomical
limitation poses even more challenges for rapid integration
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into the host vascular system after transplantation. There-
fore, it is essential to develop novel approaches to signifi-
cantly reduce the time needed for rapid anastomosis and
enhance functional angiogenesis between in vitro bioengi-
neered tissue and host tissues.
Similar to the results of our previous study,18 we found
that coculture of SCAP and HUVEC at a ratio of 1:5 in-
creases tubule formation. However, the mechanism is still
unclear. Previous studies have shown that ECs and DPSCs
secrete an array of growth factors that are beneficial for the
FIG. 1. Characterization of stem cells from apical papilla (SCAP). (A) Flow cytometry results of mesenchymal stem cell
markers CD105, CD45, STRO-1, CD73, and CD90. (B) Immunofluorescence imaging of bIII-tubulin after 3 weeks of
induction ( · 100). (C) Oil Red O staining of lipid droplets after 3 weeks of induction ( · 4). (D) Alizarin Red detection of
mineralization after 4 weeks of induction.
FIG. 2. In vitro Matrigel
angiogenesis assay. (A–F)
Phase-contrast images ( · 10)
of cells at 6 h after seeding
on Matrigel. Arrow showed
SCAPs (Red) which located
in confluent areas. (G–I)
Graphic representations of
the (G) relative tubular
length, (H) number of
branching points, and (I)
relative junctional area.
Data are presented as the
mean – standard deviation
(n = 5). *p< 0.05 versus
human umbilical vein endo-
thelial cells (HUVECs) alone
group.
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growth, differentiation, and functions of other cell types.31–35
ECs secrete insulin growth factor-1, endothelin-1, fibroblast
growth factor, platelet-derived growth factor, transforming
growth factor-b and bone morphogenic protein-2,32 which
are established inductors of DPSC proliferation and differen-
tiation.33,34 In addition, DPSCs secrete VEGF that enhances
the survival and differentiation of ECs.35 Furthermore, in a
coculture tubular formation assay, DPSCs carry out the func-
tions of pericyte-like cells and are located adjacent to ECs to
stabilize tube-like structures.19 To demonstrate the colocali-
zation of SCAP and HUVEC in tubular formation assay, we
stained the cells in orange and green fluorescence, respectively.
The results showed that HUVEC formed the trunk of tubular
structures, whereas SCAP located adjacent to the ECs, re-
sembling the pericyte location. SCAP are very similar to
DPSCs, both express mesenchymal markers, such as CD13,
CD29, CD44, CD73, CD90, CD105, CD146, and STRO-1,
and have multilineage differentiation abilities.5 These findings
FIG. 3. Protein and mRNA expression of vascular endothelial growth factor (VEGF) in SCAP and HUVEC. (A) Enzyme-
linked immunosorbent assay (ELISA) was performed to detect VEGF protein concentration in supernatant of SCAP,
HUVEC, and coculture of them under normoxia and hypoxia. (B) Magnetic beads were used to separate HUVEC from
SCAP after 3 h of coculture under normoxia and hypoxia. VEGF mRNA expression in each cell type was detected using
Real-time polymerase chain reaction (PCR) assay. SCAP isolated culture was regarded as control group, which were
standardized to 1 (*p < 0.05).
FIG. 4. Relative expression
levels of (A) hypoxia-induc-
ible factor 1a (HIF-1a), (B)
VEGF, (C) ephrinB2, and (D)
EphB4 at various time points
under normoxia and hypoxia
as detected by real-time
polymerase chain reaction
(PCR). Values were normal-
ized to GAPDH expression
(*p < 0.05).
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may explain why more vascular tubules reminiscent of blood
vessel networks were formed in cocultures of SCAP and
HUVEC at a ratio of 1:5.
In our study, we also found that coculture of HUVEC and
SCAP under hypoxia formed more vessel-like structures.
Since hypoxia always occur in implanted prevascularized
pulp tissue constructs, we used CoCl2 to mimic hypoxic
environment and explore its underlying mechanism. As
expected, we found that the expression of HIF-1a and
VEGF in SCAP increased significantly under hypoxia.
FIG. 6. Expression of HIF-1a, VEGF, and ephrinB2 after inhibiton of HIF-1a expression by YC-1. (A) Western blotting
showed that overexpression of HIF-1a protein was blocked by 80 mM YC-1 after 4 h under hypoxia. (B) Real-time PCR
results showed that the upregulated mRNA expression of ephrinB2 in SCAPs was reduced by 80 mM YC-1 after 2 h under
hypoxia. (C) VEGF mRNA and protein expression after inhibition of HIF-1a expression (I) Real-time PCR results showed
that the increased mRNA expression of VEGF in SCAPs was inhibited by 80 mM YC-1 after 2 h under hypoxia. (II) ELISA
showed that the VEGF protein concentration was also reduced by 80mM YC-1 after 24 h under hypoxia.
FIG. 5. Protein expression
of HIF-1a, VEGF, ephrinB2
and EphB4. (A) Protein ex-
pression of HIF-1a, ephrinB2,
and EphB4 at various time
points under normoxia and
hypoxia as detected by west-
ern blot analyses. (B–D) Re-
lative protein expression of
HIF-1a, VEGF and ephrinB2
versus control group at the
indicated time point.
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VEGF is a particularly strong stimulator of angiogenesis and
its expression increased dramatically at the mRNA level
(5.8-fold) and protein level (6.1-fold). Compared to SCAP,
HUVEC secreted less VEGF protein. Interestingly, when we
cocultured SCAP and HUVEC, VEGF concentration of
supernatant was found to be very low as well. We specu-
lated that VEGF secreted by SCAP may be metabolized by
HUVEC to accelerate the formation of vessel-like struc-
tures. To support our hypothesis, magnetic beads were used
to separate HUVEC from SCAP after 3 h of coculture, and
real-time PCR was performed to detect VEGF gene ex-
pression. Results showed that VEGF mRNA level in co-
SCAP and co-HUVEC were upregulated when they were
cocultured in hypoxia. It confirmed that the secretion of
VEGF by SCAP under coculture condition was not in-
hibited. Acceleration of vessel-like structure formation in
the coculture groups indicated that the secretion of VEGF be
metabolized by HUVEC. However, further study is needed
to elaborate the molecular processes.
Previous studies have demonstrated that vascular ephrinB2
and its cognate EphB receptors perform critical functions in
vascular development, and increased expression of ephrinB2 in
a number of tumor categories may be involved in tumor an-
giogenesis.36–38 However, the expression of ephrinB2 under
hypoxia is still controversial. Vihanto et al.15 suggested that
hypoxia upregulates the expression of EphB4 and ephrinB2 in
hypoxemic mouse skin. Conversely, Reissenweber et al.39
showed that hypoxic conditions do not influence the expression
or synthesis of EphA2, EphB4, ephrinA1, ephrinA5, and
ephrinB2 in four different human melanoma cell lines in vitro.
In contrast, we found that the mRNA expression of
ephrinB2 in SCAP was upregulated significantly under
hypoxia, but its protein expression remained low and
steady. Furthermore, the mRNA expression of EphB4 in
SCAP decreased constantly after hypoxic induction, but its
protein expression remained steady. There are presumably
several reasons for this contradictory phenomenon. First,
the in vitro models lack the regulatory effects of a real
hypoxic microenvironment expected in vivo, including se-
creted molecules and interacting cells.39 Second, there are
many complicated and varied posttranscriptional modifi-
cations involved in translating mRNA into protein, which
are not yet sufficiently defined to accurately calculate
protein concentrations from mRNA.40 Changes in the ex-
pression of proteins in response to altered oxygen levels
may be caused primarily by differences in the translational
efficiency of the mRNAs rather than changes in the mRNA
levels.
We also demonstrated that the upregulated expression of
VEGF and ephrinB2 was related to HIF-1a, which is the
major regulator of gene transcription in response to oxygen
deprivation.41 After HIF-1a was blocked by YC-1, the
mRNA and protein expression of VEGF in SCAP under
hypoxia decreased accordingly, and the mRNA expression
of ephrinB2 was also downregulated. These results indicate
that the overexpression of VEGF and ephrinB2 induced by
hypoxia is dependent on HIF-1a. This finding is in perfect
agreement with the study of Vihanto et al.,15 but contradicts
the conclusion of Sohl et al.42 The latter suggested that
neither HIF-1a nor HIF-2a are responsible for hypoxic in-
duction of ephrinB2 expression in mouse arterial ECs. There
is a strong possibility that (1) the different cells used or (2)
the distinct in vivo and in vitro environments account for
these contradictory results.
The correlation of EphB4/ephrinB2 and VEGF expression
in different cell lines is still obscure. Das et al.43 indicated
that stimulation of human hepatic stellate cells with either
ephrinB2 Fc or EphB4 Fc significantly increases VEGF
mRNA levels, whereas small interfering RNAs for ephrinB2
and EphB4 inhibit this increase. They further observed that
ephrinB2 stimulates phosphorylation of extracellular signal-
regulated kinases, which are key cell survival and prolif-
eration proteins, to regulate VEGF-A expression through
HIF-1 phosphorylation.44 Another study showed that VEGF
upregulates Delta-like 4 (DLL4) and presenilin expression,
and increases activation of Notch4, leading to upregulation
of ephrinB2 and downregulation of EphB4 in venous ECs.45
In contrast, Yang et al.46 found that VEGF-A inhibits ex-
pression of EphB4 and stimulates expression of DLL4, but
does not stimulate either Notch or ephrinB2 expression in
adult venous ECs. Pretreatment with a VEGFR-2 neutral-
izing antibody abolishes VEGF-stimulated downregulation
of EphB4, but not the upregulation of DLL4. These results
indicate that multiple molecules are possibly implicated in
the crosstalk of SCAP and HUVEC, which are currently
under investigation by our research team.
In summary, we found that coculture of HUVEC and
SCAP under hypoxia increases the formation of vessel-like
structures. To reveal the precise molecular mechanism re-
sponsible for this observation, we found that hypoxia up-
regulates both mRNA and protein expression of HIF-1a and
VEGF as well as mRNA expression of ephrinB2 in SCAP.
Furthermore, overexpression of VEGF and ephrinB2 in
SCAP under hypoxia is dependent on HIF-1a. These find-
ings indicate that VEGF might play a critical role in tissue
angiogenesis under hypoxia as it does normally, but the lack
of corresponding secretion of ephrinB2 protein will influ-
ence permanent angiogenesis of implanted tissues under
hypoxia.43 Therefore, we should focus on strategies that
increase the protein expression of ephrinB2 in SCAP under
hypoxia, and further explore the correlation between VEGF
and ephrinB2 expression.
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